P53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

Oncogene

Volumn 14, Issue 14, 1997, Pages 1735-1746

  Pirollo, Kathleen F ^a,c   Hao, Zhengmei ^a   Rait, Antonina ^a,c   Jang, Yng Ju ^a   Fee Jr , Willard E ^a   Ryan, Patricia ^b   Chiang, Yawen ^b   Chang, Esther H ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Adenovirus; Cancer; Head and neck; p53; Radiosensitization

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION; RADIOTHERAPY; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ADENOVIRIDAE;

EID: 0030969022     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201116     Document Type: Article

References (69)

1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnson H, Varhaugh JE, Akslen LA and Lonning PE. (1996). Nature Med., 2, 811-814.
2. Agarwal ML, Agarwal A, Taylor WR and Stark GR. (1995). PNAS USA, 92, 8493-8497.
3. American Cancer Society. (1993). American Cancer Society facts and figures. Publ. No. 93-400. Washington, DC: American Cancer Society.
4. American Joint Committee on Cancer. (1983). Manual for staging of cancer, 2nd ed. Philadelphia: Lippincott, pp. 25-54.
5. Awan AM, Yokes EE and Weichselbaum RR. (1991). Hematology/Oncology Clinics of North America, 5, 635-655.
6. Blau HM and Springer ML. (1995). N.E. J. Med., 333, 1204-1207.
7. Brachman DG. (1994). Seminars in Oncology, 21, 320-329.
8. Bramson JL, Graham FL and Gauldie J. (1995). Curr. Opin. in Biotech., 6, 590-595.
9. Chang F, Syrjanen S and Syrjanen K. (1995). J. Clin. Oncol., 13, 1009-1022.
10. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
11. Clayman GL, El-Naggar AK, Rith JA, Zhang WW, Goepfert H, Taylor DL and Liu TJ. (1995). Cancer Res., 55, 1-6.
12. Deffie A, Wu H, Reinke V and Lozano G. (1993). Mol. Cell. Biol., 13, 3415-3423.
13. Dimery IW and Hong WK. (1993). JNCI, 85, 95-111.
14. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
15. El-Deiry WS, Harper JW, O'Conner PM, Velculesco VE, Cannan CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 1169-1174.
16. Elstner E, Linker-Israeli M, Said J, Umiel T and Vos S. (1995). Cancer Res., 55, 2822-2830.
17. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS and Gluckman JL, (1993). Arch. Otolarying. Head and Neck Surg., 119, 1118-1122.
18. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owe-Schaub LB and Roth JA. (1993). Cancer Res., 53, 4129-4133.
19. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA. (1994). Cancer Res., 54, 2287-2291.
20. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledana A, Hellman S, Kufe DW and Weichselbaum RR. (1995). Nature Medicine, 1, 786-791.
21. Harper JW, Adami GR, Wei N, Kayomarssi K and Elledge SJ. (1993). Cell, 19, 805-816.
22. Hawkins DS, Demers GW and Galloway DA. (1996). Cancer Res., 56, 892-898.
23. Janat MF, Srivastava S, Devadas K, Chin GA, Pirollo KF and Chang EH. (1994). Mol. Cell. Diff., 2, 241-253.
24. Johnson P, Gray D, Mowat M and Benchimol S. (1991). Mol. Cell. Biol. 11, 1-11.
25. Jung M, Notario V and Dritschilo A. (1992). Cancer Res., 52, 6390-6393.
26. Kasid U, Pirollo K, Dritschilo A and Chang E. (1993). Adv. Cancer Res., 61, 195-233.
27. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
28. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. (1992). Cell, 7, 587-597.
29. Kerr JFR, Winterford CM and Harmon BV. (1994). Cancer, 73, 2013-2026.
30. Koechli OR, Schaer GN, Seifert B, Hornung R, Haller U, Eppenberger U and Muller H. (1994). Lancet, 344, 1647-1648.
31. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). PNAS USA, 89, 7491-7495.
32. Lee JM and Bernstein A. (1993). PNAS USA, 90, 5742-5746.
33. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H and Clayman GL. (1994). Cancer Res., 54, 3662-3667.
34. Liu TJ, El-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL and Clayman GL. (1995). Cancer Res., 55, 3117-3122.
35. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
36. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-848.
37. Lowe SW, Bodis S, Bardeesy N, McClatchey A, Remington L, Ruley HE, Fisher DE, Jacks T, Pelletier J and Housman DE. (1994). Cold Spring Harbor Symposium on Quantitative Biology, 59, 419-426.
38. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. (1994). Science, 266, 807-810.
39. Lowe SW. (1995). Current Opin. Onc., 7, 547-553.
40. Lutzker SG and Levine AJ. (1996). Nature Med., 2, 804-810.
41. Mittereder N, Yei S, Bachurski C, Cuppoletti J, Whitsett J, Tolstoshev P and Trapnell B. (1994). Human Gene Ther., 5, 717-729.
42. McIlwrath AJ, Vasey PA, Ross GM and Brown R. (1994). Cancer Res., 54, 3718-3722.
43. Nabeya Y, Loganzo F, Maslak P, Lai L, Deoliveira AR, Schwarth GK, Blundell ML, Altorki NK, Kelsen DP and Albino AP. (1995). Int. J. Cancer, 64, 37-46.
44. Newcomb EW. (1995). Luek. Lymphoma, 17, 211-221.
45. O'Conner PM, Jackman J, Jondel D, Bhatia K, Magrath I and Kohn KW. (1993). Cancer Res., 53, 4776-4780.
46. Oren M. (1994). Semin. Cancer Biol., 5, 221-227.
47. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W and Friend S. (1995). Cancer Res., 55, 1643-1648.
48. Pitts JD. (1994). Mol. Carcinogen., 11, 127-130.
49. Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE and Groudine M. (1995). Cancer Res., 55, 1639-1642.
50. Seachrist L. (1994). JNCI, 86, 82.
51. Setoguchi Y, Jaffe HA, Chu CS and Crystal RG. (1994). Am. J. Respir. Cell. Mol. Biol., 10, 369-377.
52. Shaw P, Bovey R, Tardy S, Sahil R, Sordat B and Costa J. (1992). PNAS USA, 89, 4495-4499.
53. Shin DM, Lee JS, Lippmann SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJC, Ro JY, Goepfert H, Ki Hong W and Hittelman WN. (1996). JNCI, 88, 519-529.
54. Silber R, Degar B, Costin D, Newcome EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN and Potmesil M. (1994). Blood, 84, 3440-3446.
55. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A and Kaleko M. (1993). Nature Gen., 5, 397-402.
56. Srivastava S, Tong YA, Devadas K, Zou ZQ, Sykes VW, Chen Y, Blattner WA, Pirollo K and Chang EH. (1992). Oncogene, 7, 987-991.
57. Srivastava S, Katayose D, Tong YA, Craid CR, McLeod DG, Moul JW, Cowan KH and Seth P. (1995). Urology, 46, 843-848.
58. Stewart FM. (1995). J. Cell. Biochem., 58, 416-423.
59. Stewart N, Hicks GG, Paraskewvas F and Mowat M. (1995). Oncogene, 10, 109-115.
60. Trapnell BC. (1995). Adv. Drug Delivery Rev., 12, 185-199.
61. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA. (1996). Nature Med., 2, 72-79.
62. Weichselbaum RR, Dahlberg W, Beckett M, Karison T, Miller D, Clark J and Erwin TJ. (1986). PNAS USA, 83, 2684-2688.
63. Weichselbaum RR, Beckett MA, Schwartz JL and Dritschilo A. (1988). Int. J. Radiation Oncology Biol. Phys., 15, 575-579.
64. Wu SG and El-Deiry WS. (1996). Nature Med., 2, 255-256.
65. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
66. Yang C, Cirielli C, Capogrossi MC and Passaniti A. (1995). Cancer Res., 55, 4210-4213.
67. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E and Wilson JM. (1994). PNAS USA, 91, 4407-4411.
68. Yang Y, Li Q, Ertl HC and Wilson JM. (1995). J. Virol, 69, 2004-2015.
69. Yonish-Rouach E, Resnitzky D, Lotem J, Sacks L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.